Terms: = Germ cell tumor AND HERPUD1, ENSG00000051108, 9709, Q15011, SUP, Mif1, KIAA0025, HERP AND Treatment
6 results:
1. Focusing on scRNA-seq-Derived T cell-Associated Genes to Identify Prognostic Signature and Immune Microenvironment Status in Low-Grade Glioma.
Wen J; Huang Q; Yao J; Wei W; Li Z; Zhang H; Chang S; Pei H; Cao Y; Li H
Mediators Inflamm; 2023; 2023():3648946. PubMed ID: 37292257
[TBL] [Abstract] [Full Text] [Related]
2. A Systematic Comparison of Dose Distributions Delivered in
Trofimov AV; Aronow ME; Gragoudas ES; Keane FK; Kim IK; Shih HA; Bhagwat MS
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):501-510. PubMed ID: 35878716
[TBL] [Abstract] [Full Text] [Related]
3. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
[TBL] [Abstract] [Full Text] [Related]
4. Influence of beam incidence and irradiation parameters on stray neutron doses to healthy organs of pediatric patients treated for an intracranial tumor with passive scattering proton therapy.
Bonfrate A; Farah J; De Marzi L; Delacroix S; Hérault J; Sayah R; Lee C; Bolch WE; Clairand I
Phys Med; 2016 Apr; 32(4):590-9. PubMed ID: 27050170
[TBL] [Abstract] [Full Text] [Related]
5. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
Cheng M; Quail MR; Gingrich DE; Ott GR; Lu L; Wan W; Albom MS; Angeles TS; Aimone LD; Cristofani F; Machiorlatti R; Abele C; Ator MA; Dorsey BD; Inghirami G; Ruggeri BA
Mol Cancer Ther; 2012 Mar; 11(3):670-9. PubMed ID: 22203728
[TBL] [Abstract] [Full Text] [Related]
6. Evidence of galectin-1 involvement in glioma chemoresistance.
Le Mercier M; Lefranc F; Mijatovic T; Debeir O; Haibe-Kains B; Bontempi G; Decaestecker C; Kiss R; Mathieu V
Toxicol Appl Pharmacol; 2008 Jun; 229(2):172-83. PubMed ID: 18313712
[TBL] [Abstract] [Full Text] [Related]
